GLP-2 Use: From Data to Real Life Management of Patients With Intestinal Failure (SU23)

Breakout

Date & Time:

March 23, 2025

10:30 AM – 12:00 PM ET

Format:

In Person & Virtual

CE Credits:

1.5 Hours

UAN: JA0002345-0000-25-028-L01-P

Course level:

Intermediate/Advanced

Pediatric Content

session objectives:

What You'll Learn

LEARNING OBJECTIVES

  • Identify the indications for glucagon-like peptide-2 (GLP-2) use in intestinal failure.
  • Evaluate data on GLP-2 to guide evidence-based decision making in clinical practice.
  • Develop strategies for weaning parenteral nutrition (PN) and advancing oral and enteral nutrition.
  • Enhance understanding of the real-world impact of GLP-2 therapy.

 

Topics & Presenters

GLP-2 Therapies: Effectiveness and Safety

David Mercer
MD, PhD, FRCS(C), FACS

Director of the Intestinal Rehabilitation Program

University of Nebraska Medical Center

Professor of Surgery

Division of Transplant Surgery, University of Nebraska Medical Center

Omaha, NE

From Clinical Trials to Clinical Practice: Real-World Impact of GLP-2 Therapy

Sivan Kinberg
MD

Director, Pediatric Intestinal Rehabilitation Center

Columbia University Irving Medical Center

Assistant Professor of Pediatrics

Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Columbia University Irving Medical Center

New York, NY

Practical Strategies for Weaning Parenteral Nutrition and Advancing Oral and Enteral Nutrition

Christine Hoyer
MS, RD, CSP, CDN, CNSC

Pediatric Nutrition Support Dietitian

NewYork-Presbyterian Morgan Stanley Children’s Hospital

New York, NY

Moderators:

Sivan Kinberg

MD

Director, Pediatric Intestinal Rehabilitation Center

Columbia University Irving Medical Center

Assistant Professor of Pediatrics

Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Columbia University Irving Medical Center

New York, NY